rhinoplasty surgery. Intraoperative and postprocedural complications and disorders of the respiratory system, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: Lidocaine group: 1.5 mg / kg lidocaine intravenously 20 minutes before surgery completion. Intervention 2: Intervention group: Intervention grou
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Referral for elective rhinoplasty surgery Age 18-45 years Lack of known allergies to the drugs used in the present study No pregnancy No drug addiction Do not use psychotropic drugs Perform surgery under general anesthesia Classification of ASA class, I-II
Exclusion criteria
Exclusion criteria: Taking painkillers and sedatives 24 hours before surgery History of heart disease, nervous system, and neurological disorders Patient with a history of previous rhinoplasty History of seizures Duration of anesthesia and surgery more than 2 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Restlessness when waking up from anesthesia. Timepoint: During anesthesia until the end of the patient's presence in the recovery room, the patient's vital signs will be measured. Also, during the presence at recovery, the RASS and NRS questionnaires will be filled in. Method of measurement: After extubation and transfer of the patient to recovery room, the patient's restlessness will be recorded by the RASS scale every 10 minutes until discharge from the recovery by a trained nurse who does not know the patient group. Also, after transferring the patient to recovery room, the amount of postoperative pain will be recorded by the Numerical Pain Measurement Scale (NRS) every 10 minutes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSafoora Omidvar
Arak University of Medical Sciences
Outcome results
None listed